Haematology

The Department of Hematology at the Fourth Affiliated Hospital of Harbin Medical University combines clinical care, research, teaching and professional training. It is a hematological disease treatment and research center in northeast China and hosts the Heilongjiang hemophilia medical quality control and treatment centers, a hemophilia alliance center for the three northeastern provinces, and a center for standardized platelet disorder care. It grants doctoral and master's degrees at Harbin Medical University. The department has two clinical wards with 40 beds and 18 medical and nursing staff, including five professors or associate professors, one doctoral supervisor and one master's supervisor; 70% of its physicians hold doctorates. It undertakes national and provincial research projects. It diagnoses and treats leukemia, lymphoid diseases including lymphoma and myeloma, myeloproliferative diseases, enlarged lymph nodes or spleen, unexplained fever, anemia, platelet disorders and bleeding or coagulation disorders. The hospital states that diagnosis and treatment incorporate molecular and genetic testing and standardized therapies aligned with international practice. A multidisciplinary team with other departments treats complications of hemophilia. The department applies new techniques for complex and severe cases, individualized hemophilia treatment using pharmacokinetics (PK), and molecular targeted therapies for hematological malignancies including lymphoma, multiple myeloma and acute and chronic leukemia. It also provides health education, chronic disease management and free public consultations, including regular education for people with hemophilia and lymphoma. Its stated goal is patient-centered, individualized care.